Observational, multicenter, prospective study to assess the impact on patients' outcome of a systematic screening of oncogenic drivers in advanced cancer: The GETHI XX-16 study.

Authors

null

Carmen Beato

Hospital Virgen de la Macarena, Sevilla, Spain

Carmen Beato , Paloma Navarro , JF Rodriguez-Moreno , L Miguel Navarro , Beatriz Jimenez Munarriz , Gema Bruixola , Carmen Balana , MD Fenor , Jose Fuster , Francisco Zambrana , Elena Sevillano , Elena Vila-Navarro , Esther Noguerón , Xabier Mielgo Rubio , Antonio Viudez , Maria Dolores Mediano , Juan Antonio Virizuela , Sergio Ruiz , Elena Mata , Jesus Garcia-Donas Sr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics and Tumor Biology (Nonimmuno)

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3082)

DOI

10.1200/JCO.2019.37.15_suppl.3082

Abstract #

3082

Poster Bd #

74

Abstract Disclosures